Shares of Aurora Cannabis Inc. (NYSE:ACB – Get Rating) have been assigned a consensus recommendation of "Hold" from the eleven analysts that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $4.38.

Several research analysts recently issued reports on the company. Stifel Nicolaus raised Aurora Cannabis from a "sell" rating to a "hold" rating and set a $2.15 target price on the stock in a research report on Monday, June 6th. Atb Cap Markets raised Aurora Cannabis from an "underperform" rating to a "sector perform" rating in a research report on Thursday. Canaccord Genuity Group raised Aurora Cannabis from a "sell" rating to a "hold" rating in a research report on Wednesday. Cantor Fitzgerald raised Aurora Cannabis from a "neutral" rating to an "overweight" rating in a research report on Friday, June 24th. Finally, Piper Sandler reduced their target price on Aurora Cannabis from $4.00 to $3.00 and set a "neutral" rating on the stock in a research report on Wednesday.

Aurora Cannabis Trading Down 1.6 %

Shares of NYSE ACB opened at $1.20 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 5.13 and a quick ratio of 4.76. The stock has a market capitalization of $272.16 million, a P/E ratio of -0.20 and a beta of 2.64. Aurora Cannabis has a 1-year low of $1.12 and a 1-year high of $8.69. The business has a fifty day moving average price of $1.52 and a 200 day moving average price of $2.20.

Institutional Inflows and Outflows

Aurora Cannabis Company Profile

(Get Rating)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Further Reading

• Get a free copy of the StockNews.com research report on Aurora Cannabis (ACB)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
• Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.